Last $5.21 USD
Change Today +0.04 / 0.77%
Volume 378.5K
NEO On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael T. Dent M.D.

Founder, Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance Committee, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 2 different organizations across 3 different industries.

See Board Relationships
51$51,241

Background*

Dr. Michael T. Dent, M.D. is the Founder and Managing Partner of Inlight Capital Partners. Dr. Dent is the Founder of MedOfficedirect.com. He founded Neogenomics Inc. in April 2003 and served as its Managing Director and Secretary also its President and Chief Medical Officer from April 2003 to April 2005. He founded Neogenomics Laboratories Inc. Prior to that, he served as the President and Chief Executive Officer NeoGenomics Inc. since June 2001. He founded the Naples ...

Read Full Background

Corporate Headquarters*

12701 Common Wealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

Founder, Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance Committee
Founder and Director

Education*

BS 1986
Davidson College
MD 1992
University of South Carolina
Unknown/Other Education
The American College of Obstetricians and Gynecologists

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$40,000
Total Calculated Compensation$51,241
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.21 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.